GlaxoSmithKline P.L.C. and Pfizer Inc. announced yesterday an unusual deal that would combine their HIV operations into a new company that would account for almost 20 percent of sales of drugs to fight the virus.
Copyright PHILY - Philly.com
GlaxoSmithKline P.L.C. and Pfizer Inc. announced yesterday an unusual deal that would combine their HIV operations into a new company that would account for almost 20 percent of sales of drugs to fight the virus.